Varenicline and the evaluation of neuropsychiatric adverse events in smokers
- PMID: 21550436
- DOI: 10.1016/j.biopsych.2011.04.012
Varenicline and the evaluation of neuropsychiatric adverse events in smokers
Comment on
-
A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.Biol Psychiatry. 2011 Jun 1;69(11):1075-82. doi: 10.1016/j.biopsych.2010.12.005. Epub 2011 Feb 3. Biol Psychiatry. 2011. PMID: 21295286 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
